Response rate
Showing 1 - 25 of >10,000
Response Rate in Patients With Advanced NSCLC on ICI
Recruiting
- Non Small Cell Lung Cancer Metastatic
- Diabetes Mellitus
- Pembrolizumab
-
Assiut, EgyptAssiut university
Oct 20, 2023
Oral Thrombopoietin Receptor Agonist in Pediatric Chronic ITP
Not yet recruiting
- Thrombopoietin Receptor Agonist
- (no location specified)
May 4, 2023
Rectal Cancer, Rectal Cancer Stage II, Rectal Cancer Stage III Trial in Guangzhou (drug, radiation, procedure, other)
Recruiting
- Rectal Cancer
- +3 more
- Capecitabine, Oxaliplatin
- +3 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Sep 19, 2022
"Online Surveys" in Perioperative Knee Anterior Cruciate
Not yet recruiting
- Anterior Cruciate Ligament Rupture
- knee brace cold therapy
- (no location specified)
Jun 14, 2022
Simple Blood Test to Reduce Unnecessary Adverse Effects From
Not yet recruiting
- Pathological Response Rate, Circulating Tumour DNA
- MeD-seq
- (no location specified)
Sep 6, 2023
Objective Response Rate Trial in Wuhan (GM-CSF)
Recruiting
- Objective Response Rate
-
Wuhan, Hubei, ChinaRenmin Hospital of Wuhan University
Feb 25, 2023
Breast Cancer Trial in Tucson, Albuquerque (Pegylated liposomal doxorubicin)
Completed
- Breast Cancer
- Pegylated liposomal doxorubicin
-
Tucson, Arizona
- +1 more
Jan 9, 2023
Advanced Breast Cancer, Objective Response Rate, Trastuzumab Emtansine Trial in Nanjing (Trastuzumab Emtansine (T-DM1))
Recruiting
- Advanced Breast Cancer
- +2 more
- Trastuzumab Emtansine (T-DM1)
-
Nanjing, Jiangsu, ChinaJiangSu Province Hospital/ The First Affiliated Hospital of Nanj
Nov 5, 2023
Rate to Ceftriaxone 1g IM in Gonorrhoea :French Retrospective
Completed
- Gonorrhea
-
Montpellier, FranceUhmontpellier
Oct 18, 2021
Objective Response Rate (ORR) Trial (Envafolimab, Lenvatinib Combined With TACE)
Not yet recruiting
- Objective Response Rate (ORR)
- Envafolimab, Lenvatinib Combined With TACE
- (no location specified)
Oct 13, 2022
Breast Cancer Stage IV Trial in Mansoura (comparing both arms as regard the objective response rate, toxicity profile, quality
Recruiting
- Breast Cancer Stage IV
- comparing both arms as regard the objective response rate, toxicity profile, quality of life, progression free survival
-
Mansoura, Dakahlia, EgyptOncology center mansoura university
Jan 1, 2023
Breathing Maneuvers for Inducible Myocardial Perfusion Deficits
Recruiting
- Coronary Artery Disease, Hyperventilation, Breath-hold, Pulse Rate
- 4 minute breathing maneuver
-
Montréal, Quebec, CanadaThe Research Institute of the McGill University Health Center
Aug 23, 2022
Heart Failure Trial in Valencia (Echocardiography, Minnesota Living Heart Failure Questionnaire (MLHF), Six minute walk test)
Completed
- Heart Failure
- Echocardiography
- +3 more
-
Valencia, SpainHospital Clínico Universitario La Fe
Jan 19, 2022
Autonomic Dysfunction, Inflammatory Response, Chronic Kidney Diseases Trial in Taipei (heart rate variability biofeedback)
Recruiting
- Autonomic Dysfunction
- +2 more
- heart rate variability biofeedback
-
Taipei, TaiwanTri-Service Medical Center
Sep 26, 2022
Infertility, Female, PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries Trial (metformin)
Not yet recruiting
- Infertility, Female
- PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
- (no location specified)
Mar 2, 2023
Cancer, Melanoma Trial in Worldwide (Dabrafenib, Trametinib)
Completed
- Cancer
- Melanoma
-
Guangzhou, Guangdong, China
- +12 more
Jan 4, 2022
Smoking, Smoking Cessation Trial in Madison (Rate Emotional Response, Rate Impact of Message)
Completed
- Smoking
- Smoking Cessation
- Rate Emotional Response
- Rate Impact of Message
-
Madison, WisconsinUniversity of Wisconsin
Apr 18, 2023
Ventricular Pacing With Rate Response, Bradycardia Trial in Minneapolis (Calyan Pacemaker)
Not yet recruiting
- Ventricular Pacing With Rate Response
- Bradycardia
- Calyan Pacemaker
-
Minneapolis, MinnesotaUniversity of Minnesota
Sep 21, 2023
Heart Failure Trial in Malaga (MPP ON)
Completed
- Heart Failure
- MPP ON
-
Malaga, SpainHospital Virgen de la Victoria
Feb 18, 2022
Left Ventricular Systolic Dysfunction, Sudden Cardiac Death Trial in Birmingham (regadenoson)
Active, not recruiting
- Left Ventricular Systolic Dysfunction
- Sudden Cardiac Death
-
Birmingham, AlabamaUAB
Mar 11, 2022
Recurrent Cervical Carcinoma, Metastatic Cervical Carcinoma, Persistent Cervical Carcinoma Trial in Beijing (Tislelizumab plus
Recruiting
- Recurrent Cervical Carcinoma
- +9 more
- Tislelizumab plus radiotherapy
-
Beijing, Beijing, ChinaLei Li
Apr 1, 2022
Heart Rate Recovery Responses to Repeated Active Stand Protocols
Recruiting
- Heart Rate Response
- Orthostasis
- Active Stand
-
Dublin, IrelandClinical Research Facility, St James's Hospital
May 3, 2022
IL17 Rate and Spondyloarthritis
Recruiting
- Spondylarthritis
- Blood sample
-
Nice, FranceCHU de NICE
Oct 21, 2022
Hemodynamic Instability Trial in Islamabad (Dexmedetomidine Injection [Precedex], Normal Saline)
Not yet recruiting
- Hemodynamic Instability
- Dexmedetomidine Injection [Precedex]
- Normal Saline
-
Islamabad, Federal, PakistanDeparment of Anesthesia and Critical Care Medicine, Pakistan Ins
Oct 22, 2023
Acute Physiological Effects of Organic Guayusa Extract Trial in Iowa City (Acute Moderate-Dose Guayusa Extract Supplementation,
Completed
- Acute Physiological Effects of Organic Guayusa Extract
- Acute Moderate-Dose Guayusa Extract Supplementation
- +2 more
-
Iowa City, IowaIntegrative Laboratory of Applied Physiology and Lifestyle Medic
Jun 30, 2023